BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 17353506)

  • 1. Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced beta-cell apoptosis in h-IAPP transgenic mice.
    Lin CY; Gurlo T; Kayed R; Butler AE; Haataja L; Glabe CG; Butler PC
    Diabetes; 2007 May; 56(5):1324-32. PubMed ID: 17353506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes.
    Huang CJ; Lin CY; Haataja L; Gurlo T; Butler AE; Rizza RA; Butler PC
    Diabetes; 2007 Aug; 56(8):2016-27. PubMed ID: 17475933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes.
    Matveyenko AV; Butler PC
    Diabetes; 2006 Jul; 55(7):2106-14. PubMed ID: 16804082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro model of early islet amyloid polypeptide (IAPP) fibrillogenesis using human IAPP-transgenic mouse islets.
    Henson MS; Buman BL; Jordan K; Rahrmann EP; Hardy RM; Johnson KH; O'Brien TD
    Amyloid; 2006 Dec; 13(4):250-9. PubMed ID: 17107885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes.
    Matveyenko AV; Butler PC
    ILAR J; 2006; 47(3):225-33. PubMed ID: 16804197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP.
    Meier JJ; Kayed R; Lin CY; Gurlo T; Haataja L; Jayasinghe S; Langen R; Glabe CG; Butler PC
    Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1317-24. PubMed ID: 16849627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the amyloid-degrading enzyme neprilysin in mouse islets and potential role in islet amyloidogenesis.
    Zraika S; Hull RL; Udayasankar J; Clark A; Utzschneider KM; Tong J; Gerchman F; Kahn SE
    Diabetes; 2007 Feb; 56(2):304-10. PubMed ID: 17259373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose in association with normalized islet topography in mice with beta-cell-specific overexpression of human islet amyloid polypeptide.
    Ahrén B; Winzell MS; Wierup N; Sundler F; Burkey B; Hughes TE
    Regul Pept; 2007 Oct; 143(1-3):97-103. PubMed ID: 17482289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model.
    Höppener JW; Oosterwijk C; Nieuwenhuis MG; Posthuma G; Thijssen JH; Vroom TM; Ahrén B; Lips CJ
    Diabetologia; 1999 Apr; 42(4):427-34. PubMed ID: 10230646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet pathology of non-insulin-dependent diabetes mellitus (NIDDM).
    Westermark P
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S46-8. PubMed ID: 8894481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.
    Jaikaran ET; Nilsson MR; Clark A
    Biochem J; 2004 Feb; 377(Pt 3):709-16. PubMed ID: 14565847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes.
    Butler AE; Jang J; Gurlo T; Carty MD; Soeller WC; Butler PC
    Diabetes; 2004 Jun; 53(6):1509-16. PubMed ID: 15161755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet amyloid polypeptide in proliferating pancreatic B cells during development, hyperplasia, and neoplasia in humans and mice.
    Rindi G; Terenghi G; Westermark G; Westermark P; Moscoso G; Polak JM
    Am J Pathol; 1991 Jun; 138(6):1321-34. PubMed ID: 1647136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction of transgenic mouse system expressing human islet amyloid polypeptide (IAPP)/amylin].
    Yagui K; Kanatsuka A; Makino H
    Nihon Rinsho; 1994 Oct; 52(10):2746-50. PubMed ID: 7983808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus.
    Johnson KH; O'Brien TD; Betsholtz C; Westermark P
    N Engl J Med; 1989 Aug; 321(8):513-8. PubMed ID: 2668761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular amyloid-like deposits contain unprocessed pro-islet amyloid polypeptide (proIAPP) in beta cells of transgenic mice overexpressing the gene for human IAPP and transplanted human islets.
    Paulsson JF; Andersson A; Westermark P; Westermark GT
    Diabetologia; 2006 Jun; 49(6):1237-46. PubMed ID: 16570161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of apolipoprotein E deficiency on islet amyloid deposition in human islet amyloid polypeptide transgenic mice.
    Vidal J; Verchere CB; Andrikopoulos S; Wang F; Hull RL; Cnop M; Olin KL; LeBoeuf RC; O'Brien KD; Chait A; Kahn SE
    Diabetologia; 2003 Jan; 46(1):71-9. PubMed ID: 12637985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3'-kinase-dependent pathway.
    Lin CY; Gurlo T; Haataja L; Hsueh WA; Butler PC
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6678-86. PubMed ID: 16204373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets.
    Aston-Mourney K; Hull RL; Zraika S; Udayasankar J; Subramanian SL; Kahn SE
    Diabetologia; 2011 Jul; 54(7):1756-65. PubMed ID: 21484213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid.
    Butler AE; Janson J; Soeller WC; Butler PC
    Diabetes; 2003 Sep; 52(9):2304-14. PubMed ID: 12941770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.